Company intelligence / Profile preview

Algorithm Pharmaceuticals

Zouk Mosbeh, Mount Lebanon, Lebanon

Ownership: Private
Employees: ~257
Development stage: Other

Overview

Algorithm is a regional manufacturer and marketer of generic and in-licensed pharmaceuticals, primarily focused on the Middle East and North Africa (MENA) region. Its roots trace to 1961, and it operates with GMP manufacturing capabilities, focusing on chronic and primary care indications like diabetes, dyslipidemia, hypertension, and CNS disorders. The company does not appear to have an active clinical-stage pipeline for novel therapeutics.

Therapeutic areas: CardiovascularNeurologyOtherEndocrinology
Modalities: Small moleculeGeneric drug
Industry: Contract Manufacturing Organization

Partnerships

Biologix FZCo

Beyond the preview

Go deeper on Algorithm Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Algorithm Pharmaceuticals.

Explore the full profile